ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Avior Wealth Management LLC

Avior Wealth Management LLC lowered its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 36.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 17,283 shares of the company’s stock after selling 9,835 shares during the quarter. Avior Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $567,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Baird Financial Group Inc. grew its stake in ARK Genomic Revolution ETF by 18.9% in the first quarter. Baird Financial Group Inc. now owns 42,002 shares of the company’s stock worth $1,929,000 after purchasing an additional 6,677 shares in the last quarter. High Net Worth Advisory Group LLC increased its holdings in shares of ARK Genomic Revolution ETF by 80.9% in the 1st quarter. High Net Worth Advisory Group LLC now owns 1,118 shares of the company’s stock valued at $51,000 after acquiring an additional 500 shares during the last quarter. Ancora Advisors LLC raised its position in shares of ARK Genomic Revolution ETF by 35.8% during the 1st quarter. Ancora Advisors LLC now owns 16,842 shares of the company’s stock valued at $1,494,000 after acquiring an additional 4,437 shares in the last quarter. Certified Advisory Corp lifted its stake in ARK Genomic Revolution ETF by 4.2% during the first quarter. Certified Advisory Corp now owns 8,675 shares of the company’s stock worth $398,000 after purchasing an additional 353 shares during the last quarter. Finally, Captrust Financial Advisors lifted its stake in ARK Genomic Revolution ETF by 282.2% during the second quarter. Captrust Financial Advisors now owns 34,316 shares of the company’s stock worth $1,081,000 after purchasing an additional 25,337 shares during the last quarter.

ARK Genomic Revolution ETF Price Performance

ARKG stock opened at $23.55 on Friday. The company’s fifty day simple moving average is $28.95 and its two-hundred day simple moving average is $28.46.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.